Genetic Analysis AS announces the outcome of the warrant exercise

0
106

Oslo, Norway, November 21, 2022 – On November 16, 2022, the train interval for Genetic Evaluation AS’s (“GA” or the “Firm”) warrants of sequence TO 1, issued in reference to the Firm’s IPO of models in September/October 2021, ended. No warrants of sequence TO 1 have been exercised. The rationale for that is deemed to be that the subscription value for the train of warrants of sequence TO 1 has exceeded the present share value throughout your complete train interval.

Throughout the interval November 2 till November 16, 2022, holders of warrants of sequence TO 1 have been, for every warrant, entitled to subscribe for one (1) new share in GA, at a subscription value set to NOK 9.30 per share. No warrants have been exercised, and due to this fact, the share capital and the variety of shares within the Firm stay unchanged.

For extra details about warrants of sequence TO 1, please contact:Eilert Aamodt, CFO
E-mail: [email protected]

Web site: www.genetic-analysis.com

For extra details about GA, please contact:Ronny Hermansen, CEO
E-mail: [email protected]

About Genetic Evaluation:
Genetic Evaluation AS (GA) is a science-based diagnostic firm and pioneer within the human microbiome discipline with greater than 10 years of experience in analysis and product growth. The distinctive GA-map® platform is predicated on a pre-determined multiplex targets method specialised for simultaneous evaluation of numerous micro organism in a single response. The check outcomes are generated by using the clinically validated leading edge GA-map® software program algorithm. This allows rapid outcomes with out the necessity for additional bioinformatics work. GA’s imaginative and prescient is to turn into the main firm for standardized intestine microbiota testing worldwide, and GA is dedicated to assist unlocking and restoring the human microbiome by means of its state-of-the-art know-how. GA employs a group of extremely certified staff with scientific backgrounds and competence in bioinformatics, molecular biology, and bioengineering. www.genetic-analysis.com

Desirous about studying extra about GA’s merchandise? Please go to ga-map.com

https://information.cision.com/genetic-analysis-as/r/genetic-analysis-as-announces-the-outcome-of-the-warrant-exercise,c3668938

https://mb.cision.com/Important/20846/3668938/1678910.pdf

(c) 2022 Cision. All rights reserved., supply Press Releases – English

LEAVE A REPLY

Please enter your comment!
Please enter your name here